Initially Unresectable
2 clinical trials · Condition
◉ Watch Initially Unresectable
| Record | Firm | Date |
|---|---|---|
| Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer (NCT05757336) | Lu Wang, MD, PhD | 2022-12-22 |
| Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer (NCT04984980) | Fudan University | 2020-08-01 |
Track Initially Unresectable automatically
Every clearance here is in the API, with alerts when new ones post.